Search for: "Glaxo Smith Kline"
Results 41 - 59
of 59
Sorted by Relevance
|
Sort by Date
18 Dec 2010, 2:46 pm
Now comes word that in-house attorney Lauren Stevens, who worked for Glaxo Smith Kline, has been indicted in the context of representing her client. [read post]
13 Jun 2012, 7:24 am
First, Glaxo Smith Kline earned approximately $31 billion in gross profit in 2011 (according to their annual report). [read post]
18 Mar 2021, 4:00 am
Generic drug manufacturers like Glaxo-Smith-Kline and Dr. [read post]
8 Mar 2012, 11:15 am
Cheryl Eckard provided information about Glaxo-Smith Kline’s deficient drug production standards and has likely saved lives because she came forth with the necessary information. [read post]
18 Mar 2021, 4:00 am
Generic drug manufacturers like Glaxo-Smith-Kline and Dr. [read post]
2 Aug 2009, 12:10 pm
It has frequently been reported as effective in instances such as Glaxo Smith Kline in 2003. [read post]
18 Mar 2021, 4:00 am
Generic drug manufacturers like Glaxo-Smith-Kline and Dr. [read post]
25 Feb 2014, 2:49 pm
And how truly valuable are pharmaceutical house marks such as Merck, Schering or GSK in an age in which the sector is so regulated, most purchases are surely made on bases other than whether a drug is made by one company or another, and in a sophisticated market in which consumers can understand when companies rebrand (did anyone get confused when Smith Kline and French, Beckman, Glaxo, Wellcome and Beecham evolved into GSK)? [read post]
16 Dec 2009, 3:39 am
(IP Whiteboard) Civil society, elected officials rally behind UNITAID patent pool (IP Watch) (IP Watch) (Managing IP) International policy network: Fake scare about fake drugs (IP Watch) Counterfeit medicines at WHO: off board’s agenda, still on Secretariat’s (IP Watch) Belgium: Appeal in descriptive seizure proceedings: Glaxo Smith Kline Biologicals v Novartis (EPLAW Patent Blog) Brazil: Hypermarcas consolidates its position in Brazil’s generics markets… [read post]
26 Mar 2010, 8:21 am
Federal Circuit judges Linn and Rader recognize this problem in their dissents to Ariad. (...)In view of the widely held perception that LWD was bad for biotechnology, it might come as surprise to find that major biotechnology companies Amgen, Glaxo Smith Kline, and Abbott all filed amicus briefs in Araid supporting Lilly and retention of LWD. [read post]
22 Jun 2012, 11:29 am
First, Glaxo Smith Kline earned approximately $31 billion in gross profit in 2011 (according to their annual report). [read post]
6 Jan 2022, 2:26 pm
Check it out: Cheryl Eckard Meads and the drug adulteration case against Glaxo Smith Kline, resulting in a $750 mm settlement. [read post]
6 Mar 2014, 12:41 pm
Glaxo Smith Kline Healthcare, 2006 WL 952032 (N.D. [read post]
5 Jul 2007, 10:37 am
Smith, Kline & French Laboratories, 447 So.2d 1301, 1305 (Ala. 1984).Alaska: Shanks v. [read post]
24 May 2007, 10:40 am
At bottom, preemption is about power. [read post]
28 Jun 2007, 10:16 am
OK class, for today's lesson, assume you are a major, sophisticated drug company. [read post]
8 Oct 2008, 11:50 am
Smith, Kline & French Laboratories, 447 So.2d 1301, 1303 (Ala. 1984).California: Carlin v. [read post]
2 Jun 2011, 12:46 pm
Smith, Kline & French Laboratories, 447 So.2d 1301, 1305 (Ala. 1984).AlaskaShanks v. [read post]
28 Apr 2011, 3:18 pm
By now Restatement (Second) of Torts §402A (1965) is so old as to be thought of as somewhat antediluvian. [read post]
